Wenzheng Ju

1.6k total citations
89 papers, 1.3k citations indexed

About

Wenzheng Ju is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Wenzheng Ju has authored 89 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 30 papers in Complementary and alternative medicine and 20 papers in Pharmacology. Recurrent topics in Wenzheng Ju's work include Traditional Chinese Medicine Analysis (24 papers), Natural product bioactivities and synthesis (18 papers) and Pharmacological Effects of Natural Compounds (10 papers). Wenzheng Ju is often cited by papers focused on Traditional Chinese Medicine Analysis (24 papers), Natural product bioactivities and synthesis (18 papers) and Pharmacological Effects of Natural Compounds (10 papers). Wenzheng Ju collaborates with scholars based in China, United States and Thailand. Wenzheng Ju's co-authors include Guoliang Dai, Meijuan Xu, Changyin Li, Jihong Chu, Shijia Liu, Shijia Liu, Ting Wu, Baochang Cai, Jun Zhang and Jinjun Shan and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Wenzheng Ju

85 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenzheng Ju China 21 666 307 250 204 178 89 1.3k
Baolin Bian China 23 888 1.3× 327 1.1× 329 1.3× 240 1.2× 285 1.6× 104 1.6k
Xiaolan Cheng China 28 929 1.4× 358 1.2× 390 1.6× 229 1.1× 151 0.8× 62 1.8k
HU Zhi-bi China 21 747 1.1× 319 1.0× 288 1.2× 333 1.6× 293 1.6× 85 1.5k
Kedan Chu China 25 647 1.0× 294 1.0× 179 0.7× 163 0.8× 120 0.7× 60 1.3k
Yan Liang China 23 924 1.4× 364 1.2× 516 2.1× 153 0.8× 294 1.7× 85 1.6k
Ran Joo Choi South Korea 25 977 1.5× 240 0.8× 284 1.1× 355 1.7× 309 1.7× 51 2.1k
Peiying Shi China 25 845 1.3× 339 1.1× 230 0.9× 289 1.4× 226 1.3× 59 1.5k
Ziyang Lou China 22 787 1.2× 300 1.0× 279 1.1× 178 0.9× 72 0.4× 55 1.3k
Rui‐Chao Lin China 23 844 1.3× 377 1.2× 302 1.2× 310 1.5× 286 1.6× 69 1.6k

Countries citing papers authored by Wenzheng Ju

Since Specialization
Citations

This map shows the geographic impact of Wenzheng Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenzheng Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenzheng Ju more than expected).

Fields of papers citing papers by Wenzheng Ju

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenzheng Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenzheng Ju. The network helps show where Wenzheng Ju may publish in the future.

Co-authorship network of co-authors of Wenzheng Ju

This figure shows the co-authorship network connecting the top 25 collaborators of Wenzheng Ju. A scholar is included among the top collaborators of Wenzheng Ju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenzheng Ju. Wenzheng Ju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhenyang, et al.. (2024). A mathematical multiple-dimensional strategy for Q-markers identification based on “five principles”: Tianshu Capsule for migraine treatment as an example. Journal of Ethnopharmacology. 337(Pt 1). 118848–118848. 1 indexed citations
2.
Dai, Guoliang, et al.. (2022). ACSL4 promotes colorectal cancer and is a potential therapeutic target of emodin. Phytomedicine. 102. 154149–154149. 28 indexed citations
3.
Wu, Ting, Ying Chen, Chao Jiang, et al.. (2021). Absolute protein assay for the simultaneous quantification of two epoxide hydrolases in rats by mass spectrometry–based targeted proteomics. Journal of Separation Science. 44(14). 2754–2763. 1 indexed citations
4.
Chu, Jihong, Ming Liu, Guoliang Dai, et al.. (2021). Simultaneous determination of nicotinamide and N1‐methylnicotinamide in human serum by LC–MS/MS to associate their serum concentrations with obesity. Biomedical Chromatography. 36(2). e5261–e5261. 5 indexed citations
5.
Xu, Meijuan, Ying Chen, Chao Jiang, et al.. (2021). In vitro inhibitory effects of components from Salvia miltiorrhiza on catalytic activity of three human Arachidonic acid ω-hydroxylases. Drug Metabolism and Pharmacokinetics. 43. 100402–100402. 2 indexed citations
6.
Dai, Guoliang, et al.. (2018). Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling. Phytomedicine. 56. 126–135. 62 indexed citations
7.
Liu, Shijia, et al.. (2017). Comparison of the pharmacokinetics of levetiracetam injection and levetiracetam tablets in human. Zhongguo linchuang yaolixue yu zhiliaoxue. 22(3). 294. 1 indexed citations
8.
9.
Liu, Shijia, Peidong Chen, Guoliang Dai, et al.. (2017). Pharmacokinetic and pharmacodynamic modeling of oral mitiglinide on glucose lowering in healthy Chinese volunteers. BMC Pharmacology and Toxicology. 18(1). 54–54. 1 indexed citations
10.
11.
12.
Liu, Shijia, et al.. (2013). Simultaneous determination of phenolic acids by UPLC–MS/MS in rat plasma and its application in pharmacokinetic study after oral administration of Flos Lonicerae preparations. Journal of Pharmaceutical and Biomedical Analysis. 86. 189–197. 17 indexed citations
13.
Liu, Shijia, Peidong Chen, Guoliang Dai, et al.. (2013). Analysis of isorhamnetin-3-O-neohesperidoside in rat plasma by liquid chromatography/electrospray ionization tandem mass spectrometry and its application to pharmacokinetic studies. Chinese Journal of Natural Medicines. 11(5). 572–576. 7 indexed citations
14.
Ma, Shitang, Cheng‐Tao Feng, Xiaolin Zhang, et al.. (2013). The multi-target capabilities of the compounds in a TCM used to treat sepsis and their in silico pharmacology. Complementary Therapies in Medicine. 21(1). 35–41. 20 indexed citations
15.
Chen, Peidong, Shijia Liu, Guoliang Dai, et al.. (2012). Determination of typhaneoside in rat plasma by liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 70. 636–639. 9 indexed citations
16.
Chen, Yong, Jianwei Chen, Shijia Liu, et al.. (2012). Determination of bullatacin in rat plasma by liquid chromatography–mass spectrometry. Journal of Chromatography B. 897. 94–97. 6 indexed citations
17.
Liu, Zixiu, Shijia Liu, Ling Zhou, et al.. (2011). Effects of HuangKui capsules on glibenclamide pharmacokinetics in rats. Journal of Ethnopharmacology. 139(1). 1–5. 20 indexed citations
18.
Wang, Jing & Wenzheng Ju. (2007). Determination of Simvastatin in Human Plasma by LC/MS/MS. Zhongguo yaofang. 1 indexed citations
19.
Ju, Wenzheng & Jihong Chu. (2006). Study on metabolites of scutellarin in gastrointestinal tract by UPLC-MS/MS method. Zhongguo linchuang yaolixue yu zhiliaoxue. 6 indexed citations
20.
Ju, Wenzheng. (2005). Determination of scutellarin in human plasma by LC-MS method and its clinical pharmacokinetics in Chinese healthy volunteers. Zhongguo linchuang yaolixue yu zhiliaoxue. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Baolin Bian Breakdown of academic impact, for papers by Xiaolan Cheng Breakdown of academic impact, for papers by HU Zhi-bi Breakdown of academic impact, for papers by Kedan Chu Breakdown of academic impact, for papers by Yan Liang Breakdown of academic impact, for papers by Ran Joo Choi Breakdown of academic impact, for papers by Peiying Shi Breakdown of academic impact, for papers by Ziyang Lou Breakdown of academic impact, for papers by Rui‐Chao Lin
Rankless by CCL
2026